BTG3 and colorectal carcinoma: A Kaplan–Meier analysis revealed that patients with CRC and relatively high BTG3 expression had significantly longer OS and DFS rates than those with low BTG3 expression (OS rate, p = 0.0045, Fig. 1e; DFS rate, p = 0.0011, Fig. 1f).